| Financial Year |
March 31 2023 |
| Monetary Funds |
1,873,463,014.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
208,502,633.00 |
| Advances to Suppliers |
23,168,204.36 |
| Other Receivables |
37,056,629.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,178,675,776.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,550,554.32 |
| Total Current Assets |
3,328,416,812.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
62,503,414.16 |
| Investment Properties |
333,335,907.62 |
| Fixed Assetes |
802,315,049.31 |
| Under-construction Projects |
18,587,847.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
157,006,450.21 |
| R&D expenses |
-- |
| Goodwill |
16,758,184.99 |
| Long-Term Deferred and Prepaid Expenses |
789,029.76 |
| Deferred Income Tax Assets |
63,196,692.05 |
| Other Non-Current Assets |
2,243,869.44 |
| Sub-Total of Non-Current Assets |
1,734,849,363.94 |
| Total Assets |
5,063,266,176.87 |
| Short-Term Loans |
488,794,882.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
232,773,385.57 |
| Accounts Payable |
191,706,342.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
51,704,516.51 |
| Taxes Payable |
18,520,864.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,673,892.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,462,973.48 |
| Other Current Liabilities |
2,353,121.33 |
| Sub-Total of Current Liabilities |
1,158,272,714.92 |
| Long-term Loans |
50,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,187,461.93 |
| Deferred Income Tax Liabilities |
4,982,099.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
128,218,049.26 |
| Total Liabilities |
1,286,490,764.18 |
| Paid-In Capital(Or Share Stock) |
1,363,410,323.00 |
| Capital Surplus |
991,909,560.75 |
| Surplus Reserve |
171,166,974.22 |
| LESS:Treasury Stock |
17,290,730.00 |
| Undistributed Profits |
1,208,138,116.87 |
| Minority Stockholder's Interest |
33,601,876.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,743,173,536.69 |
| Owner's Equity（Stockholder's Equity） |
3,776,775,412.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,063,266,176.87 |
